KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX)

CUSIP: 492515101

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COMMON STOCK
Total 13F shares
76,537,811
Share change
-1,216,934
Total reported value
$313,031,147
Put/Call ratio
176%
Price per share
$4.09
Number of holders
122
Value change
-$5,474,810
Number of buys
49
Number of sells
51

Quarterly Holders Quick Answers

What is CUSIP 492515101?
CUSIP 492515101 identifies KERX - KERYX BIOPHARMACEUTICALS - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) as of Q1 2018

As of 31 Mar 2018, KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) was held by 122 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 76,537,811 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, ABRAMS CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, CLEARBRIDGE, LLC, NORGES BANK, RICE HALL JAMES & ASSOCIATES, LLC, FMR LLC, and AMERIPRISE FINANCIAL INC. This page lists 122 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.